Cargando…

The Therapeutic Effect of Tacrolimus in a Mouse Psoriatic Model is Associated with the Induction of Myeloid-derived Suppressor Cells

OBJECTIVES: Topical administration of Tacrolimus (TAC) is efective in the treatment of psoriasis in human patients and in mouse models. Previously, we showed that, though promoting the proliferative expansion of CD4(+)Foxp3(+) regulatory T cells (Tregs), TNFR2 was protective in mouse psoriasis model...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Shaokui, Liao, Ping, Xi, Long, Yang, Yang, Wu, Wenzhong, Islam, Md Sahidul, Lin, Zibei, Zheng, Ying, Chen, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984933/ https://www.ncbi.nlm.nih.gov/pubmed/36879838 http://dx.doi.org/10.2478/rir-2022-0034

Ejemplares similares

Topical Application of Tetrandrine Nanoemulsion Promotes the Expansion of CD4(+)Foxp3(+) Regulatory T Cells and Alleviates Imiquimod-Induced Psoriasis in Mice
por: Chen, Shaokui, et al.
Publicado: (2022)

Enhanced uptake and anti-maturation effect of celastrol-loaded mannosylated liposomes on dendritic cells for psoriasis treatment
por: Xi, Long, et al.
Publicado: (2022)

Uptake and trafficking of different sized PLGA nanoparticles by dendritic cells in imiquimod-induced psoriasis-like mice model
por: Lin, Zibei, et al.
Publicado: (2021)

TNFR2: Role in Cancer Immunology and Immunotherapy
por: Yang, Yang, et al.
Publicado: (2021)

Effects of nanoparticles with hydrotropic nicotinamide on tacrolimus: permeability through psoriatic skin and antipsoriatic and antiproliferative activities
por: Wan, Tao, et al.
Publicado: (2017)

Inhibition of two-pore channels in antigen-presenting cells promotes the expansion of TNFR2-expressing CD4(+)Foxp3(+) regulatory T cells
por: He, Tianzhen, et al.
Publicado: (2020)

Effect of Angelica polysaccharide on mouse myeloid-derived suppressor cells
por: Shen, Jie, et al.
Publicado: (2022)

Successful induction of granulomatosis with polyangiitis with tacrolimus
por: Ramachandran, R., et al.
Publicado: (2015)

TNFR2 expression predicts the responses to immune checkpoint inhibitor treatments
por: Liao, Ping, et al.
Publicado: (2023)

Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective
por: Yang, Yang, et al.
Publicado: (2020)

Myeloid-Derived Suppressor Cells and Therapeutic Strategies in Cancer
por: Katoh, Hiroshi, et al.
Publicado: (2015)

Efficacy and safety of tacrolimus in induction therapy of patients with lupus nephritis
por: Zhou, Tianbiao, et al.
Publicado: (2019)

Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
por: Li, Kai, et al.
Publicado: (2021)

The role of CD4(+)FoxP3(+) regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment
por: Wang, Yifei, et al.
Publicado: (2021)

Myeloid-Derived Suppressor Cells as Therapeutic Target in Hematological Malignancies
por: De Veirman, Kim, et al.
Publicado: (2014)

Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
por: Law, Andrew M. K., et al.
Publicado: (2020)

Humoral and Cellular Immune Responses of COVID-19 vaccines against SARS-Cov-2 Omicron variant: a systemic review
por: Chen, Zhonghao, et al.
Publicado: (2022)

Comparison of normal versus imiquimod-induced psoriatic skin in mice for penetration of drugs and nanoparticles
por: Sun, Lin, et al.
Publicado: (2018)

Intravenous tacrolimus is a superior induction therapy for acute severe ulcerative colitis compared to oral tacrolimus
por: Shimizu, Hiromichi, et al.
Publicado: (2021)

Down-Regulation of the Oncogene PTTG1 via the KLF6 Tumor Suppressor during Induction of Myeloid Differentiation
por: Chen, Pei-Yi, et al.
Publicado: (2013)

Interleukin-12 exacerbates Sjögren's syndrome through induction of myeloid-derived suppressor cells
por: Qi, Jingjing, et al.
Publicado: (2019)

Drug-induced CYP induction as therapy for tacrolimus intoxication
por: Hoppe, John M., et al.
Publicado: (2022)

Isolation of human and mouse myeloid-derived suppressor cells for metabolic analysis
por: Choi, Jee Eun, et al.
Publicado: (2022)

Induction of differentiation in psoriatic keratinocytes by propylthiouracil and fructose()
por: Arul, Santhosh, et al.
Publicado: (2016)

Artepillin C Reduces Allergic Airway Inflammation by Induction of Monocytic Myeloid-Derived Suppressor Cells
por: Martins, Núbia Sabrina, et al.
Publicado: (2021)

The therapeutic effect of switching from tacrolimus to low-dose cyclosporine A in renal transplant recipients with BK virus nephropathy
por: Chen, Xu-Tao, et al.
Publicado: (2019)

Myeloid-Derived Suppressor Cells in Solid Tumors
por: Ma, Tianmiao, et al.
Publicado: (2022)

The Role and Potential Therapeutic Application of Myeloid-Derived Suppressor Cells in Allo- and Autoimmunity
por: Zhang, Qi, et al.
Publicado: (2015)

Myeloid derived suppressor cells – a new therapeutic target in the treatment of cancer
por: Wesolowski, Robert, et al.
Publicado: (2013)

Immunosuppressive Role of Myeloid-Derived Suppressor Cells and Therapeutic Targeting in Lung Cancer
por: Ma, Jie, et al.
Publicado: (2018)

Metabolic and functional reprogramming of myeloid-derived suppressor cells and their therapeutic control in glioblastoma
por: Won, Woong-Jai, et al.
Publicado: (2019)

Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches
por: Thyagarajan, Anita, et al.
Publicado: (2019)

Therapeutic Values of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma: Facts and Hopes
por: Wang, Yijun, et al.
Publicado: (2021)

Myeloid-Derived Suppressor Cells as Therapeutic Targets in Uterine Cervical and Endometrial Cancers
por: Mabuchi, Seiji, et al.
Publicado: (2021)

Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets
por: Al-Mterin, Mohammad A., et al.
Publicado: (2022)

The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers
por: Fan, Rong, et al.
Publicado: (2022)

Umbilical cord mesenchymal stem cells enhance the therapeutic effect of imipenem by regulating myeloid-derived suppressor cells in septic mice
por: Long, Xianming, et al.
Publicado: (2021)

Myeloid Derived Suppressor Cells in Chronic Myeloid Leukemia
por: Giallongo, Cesarina, et al.
Publicado: (2015)

Therapeutic targeting of myeloid-derived suppressor cells involves a novel mechanism mediated by clusterin
por: Zhou, Junmin, et al.
Publicado: (2016)

The mTOR Deficiency in Monocytic Myeloid-Derived Suppressor Cells Protects Mouse Cardiac Allografts by Inducing Allograft Tolerance
por: Li, Jiawei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e231j7uihiudqplgt55a4vm8ng